Mesoblast (MESO) has the following price history information. Looking back at MESO historical stock prices for the last five trading days, on April 22, 2024, MESO opened at $5.39, traded as high as $5.53 and as low as $5.26, and closed at $5.53. Trading volume was a total of 277.70K shares. On April 23, 2024, MESO opened at $5.86, traded as high as $6.17 and as low as $5.84, and closed at $6.00. Trading volume was a total of 630.40K shares. On April 24, 2024, MESO opened at $6.08, traded as high as $6.24 and as low as $5.82, and closed at $6.22. Trading volume was a total of 199.30K shares. On April 25, 2024, MESO opened at $6.13, traded as high as $6.28 and as low as $5.90, and closed at $6.15. Trading volume was a total of 239.80K shares. On April 26, 2024, MESO opened at $6.04, traded as high as $6.36 and as low as $6.04, and closed at $6.24. Trading volume was a total of 323.80K shares.

MESO Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Mesoblast shares, starting with a $10,000 purchase of MESO, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	04/29/2014
End date:	04/26/2024
Start price/share:	$43.44
End price/share:	$6.24
Dividends collected/share:	$0.00
Total return:	-85.64%
Average Annual Total Return:	-17.64%
Starting investment:	$10,000.00
Ending investment:	$1,436.03
Years:	10.00

MESO Historical Price Range
Date	Open	High	Low	Close	Volume
04/22/2024	$5.39	$5.53	$5.26	$5.53	277.70K
04/23/2024	$5.86	$6.17	$5.84	$6.00	630.40K
04/24/2024	$6.08	$6.24	$5.82	$6.22	199.30K
04/25/2024	$6.13	$6.28	$5.90	$6.15	239.80K
04/26/2024	$6.04	$6.36	$6.04	$6.24	323.80K

About Mesoblast

Mesoblast has developed a range of late stage product candidates derived from its proprietary mesenchymal lineage cell therapy technology platforms. Remestemcel-L is Co.'s first generation mesenchymal lineage stromal cell product platform and is being develop for the treatment of systemic inflammatory diseases including: pediatric steroid refractory acute graft versus host disease; acute respiratory distress syndrome; and biologic refractory inflammatory bowel disease. Rexlemestrocel-L is Co.'s second generation mesenchymal lineage precursor cell product platform and is being develop for the treatment of: chronic heart failure; and chronic low back pain due to degenerative disc disease.

MESO Historical Closing Prices
Date	Close
04/22/2024	$5.53
04/23/2024	$6.00
04/24/2024	$6.22
04/25/2024	$6.15
04/26/2024	$6.24

MESO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.